NBIX 8-K 2026-09-28

NEUROCRINE BIOSCIENCES INC (NBIX) 8-K dated 2026-09-28 — accession 0000914475-26-000045. This URL is the filing, not the NBIX hub.

NEUROCRINE BIOSCIENCES INC (NBIX) is a drug manufacturers - specialty & generic company listed on US.

NEUROCRINE BIOSCIENCES INC filed a 8-K on 2026-09-28. Accession 0000914475-26-000045.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NBIX revenue for 2025-12-31 was $2.86B. Net income was $478.6M. Revenue was up 21.4% from 2024-12-31 to 2025-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.

Not investment advice. The NBIX SEC hub lists recent forms. The stock page is the research view.